Global Dermatology Drug Competitive Landscape Professional Research Report 2024

Research Summary

A dermatology drug is a pharmaceutical substance specifically formulated to treat various skin conditions and disorders, ranging from common skin ailments like acne, eczema, and psoriasis to more severe conditions such as skin cancer. These drugs can be administered topically as creams, ointments, or lotions, or in some cases, taken orally or through injections. Dermatology drugs work by targeting specific pathways, cells, or mechanisms involved in the development of skin disorders, aiming to alleviate symptoms, reduce inflammation, regulate immune responses, or inhibit abnormal cell growth. These drugs play a crucial role in managing skin health, promoting healing, and enhancing the quality of life for individuals dealing with dermatological issues.

According to DIResearch's in-depth investigation and research, the global Dermatology Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Dermatology Drug include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Valeant, Merz Pharma, GlaxoSmithKline, LEO Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Dermatology Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Dermatology Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Dermatology Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dermatology Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Dermatology Drug Include:

AbbVie

Johnson & Johnson

Bayer

Galderma

Bristol-Myers Squibb

Novartis

Pfizer

Valeant

Merz Pharma

GlaxoSmithKline

LEO Pharma

Dermatology Drug Product Segment Include:

External Drug

Oral Drug

Injection Solution

Dermatology Drug Product Application Include:

Psoriasis

Skin Infections

Acne

Dermatitis

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Dermatology Drug Industry PESTEL Analysis

Chapter 3: Global Dermatology Drug Industry Porter's Five Forces Analysis

Chapter 4: Global Dermatology Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Dermatology Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Dermatology Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Dermatology Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Dermatology Drug Market Overview

1.1 Product Definition and Statistical Scope

1.2 Dermatology Drug Product by Type

1.2.1 Global Dermatology Drug Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 External Drug

1.2.3 Oral Drug

1.2.4 Injection Solution

1.3 Dermatology Drug Product by Application

1.3.1 Global Dermatology Drug Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Psoriasis

1.3.3 Skin Infections

1.3.4 Acne

1.3.5 Dermatitis

1.3.6 Others

1.4 Global Dermatology Drug Market Revenue Analysis (2019-2030)

1.5 Dermatology Drug Market Development Status and Trends

1.5.1 Dermatology Drug Industry Development Status Analysis

1.5.2 Dermatology Drug Industry Development Trends Analysis

2 Dermatology Drug Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Dermatology Drug Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Dermatology Drug Market Analysis by Regions

4.1 Dermatology Drug Overall Market: 2023 VS 2024 VS 2030

4.2 Global Dermatology Drug Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Dermatology Drug Revenue and Market Share by Region (2019-2024)

4.2.2 Global Dermatology Drug Revenue Forecast by Region (2025-2030)

5 Global Dermatology Drug Market Size by Type and Application

5.1 Global Dermatology Drug Market Size by Type

5.2 Global Dermatology Drug Market Size by Application

6 North America

6.1 North America Dermatology Drug Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Dermatology Drug Market Size by Type

6.4 North America Dermatology Drug Market Size by Application

6.5 North America Dermatology Drug Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Dermatology Drug Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Dermatology Drug Market Size by Type

7.4 Europe Dermatology Drug Market Size by Application

7.5 Europe Dermatology Drug Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Dermatology Drug Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Dermatology Drug Market Size by Type

8.4 China Dermatology Drug Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Dermatology Drug Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Dermatology Drug Market Size by Type

9.4 APAC (excl. China) Dermatology Drug Market Size by Application

9.5 APAC (excl. China) Dermatology Drug Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Dermatology Drug Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Dermatology Drug Market Size by Type

10.4 Latin America Dermatology Drug Market Size by Application

10.5 Latin America Dermatology Drug Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Dermatology Drug Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Dermatology Drug Market Size by Type

11.4 Middle East & Africa Dermatology Drug Market Size by Application

11.5 Middle East & Africa Dermatology Drug Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Dermatology Drug Market Revenue by Key Manufacturers (2020-2024)

12.2 Dermatology Drug Competitive Landscape Analysis and Market Dynamic

12.2.1 Dermatology Drug Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 AbbVie

13.1.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 AbbVie Dermatology Drug Product Portfolio

13.1.3 AbbVie Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Johnson & Johnson

13.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Johnson & Johnson Dermatology Drug Product Portfolio

13.2.3 Johnson & Johnson Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Bayer

13.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Bayer Dermatology Drug Product Portfolio

13.3.3 Bayer Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Galderma

13.4.1 Galderma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Galderma Dermatology Drug Product Portfolio

13.4.3 Galderma Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Bristol-Myers Squibb

13.5.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Bristol-Myers Squibb Dermatology Drug Product Portfolio

13.5.3 Bristol-Myers Squibb Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Novartis

13.6.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Novartis Dermatology Drug Product Portfolio

13.6.3 Novartis Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Pfizer

13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Pfizer Dermatology Drug Product Portfolio

13.7.3 Pfizer Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Valeant

13.8.1 Valeant Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Valeant Dermatology Drug Product Portfolio

13.8.3 Valeant Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Merz Pharma

13.9.1 Merz Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Merz Pharma Dermatology Drug Product Portfolio

13.9.3 Merz Pharma Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 GlaxoSmithKline

13.10.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 GlaxoSmithKline Dermatology Drug Product Portfolio

13.10.3 GlaxoSmithKline Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 LEO Pharma

13.11.1 LEO Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 LEO Pharma Dermatology Drug Product Portfolio

13.11.3 LEO Pharma Dermatology Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Dermatology Drug Industry Chain Analysis

14.2 Dermatology Drug Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Dermatology Drug Typical Downstream Customers

14.4 Dermatology Drug Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support